CLB logo

CORE LABORATORIES INC

CLBNYSE
πŸ† #3023 by market capEarnings Oct 28US Equity
$295.04β–Ό $1.15 (βˆ’0.39%)
Simulated price
πŸ””
Track CLB
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.4%
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$477M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+0.3%
Slowing
πŸ“ŠGross Margin
19.5%
Thin
πŸ’΅FCF Margin
2.3%
Thin
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
68
Fair
No chart data available for CLB.

Trading Snapshot

Day Range
$290.49 – $298.76
52-Week Range
$9.79 – $20.36
Volume
$4.49B
Avg Volume
$3.45B
Shares Outstanding
46.1M
Next Earnings
Dec 15, 2026

Fundamentals Snapshot

Annual Revenue
$527M
Last Q Revenue
$125M
P/E Ratio
19.6
P/S Ratio
0.9x
EPS (TTM)
$0.52
Dividend Yield
0.39%
Dilution (1yr)
βˆ’2.7%

Why Investors Own CLB

  • βœ“High-growth profile β€” revenue up +46.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 64% gross margin and 30% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

CLB logo

CORE LABORATORIES INC

CLB
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$527Mβ–² +0.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
17.9%β–² +6.1% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$50Mβ–Ό βˆ’13.8% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$22Mβ–Ό βˆ’48.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
46.5Mβ–Ό βˆ’2.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$141Mβ–² +$20M YoY
StockOtter Β· stockotter.space

About CORE LABORATORIES INC

Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
68/100

Analyst Price Target

β“˜
Average Target
$354.71
β–² +20.2% Upside
High Target$398.19
Low Target$296.66
Based on 35 analysts

Latest News & Updates